BFOCX | VITAX | BFOCX / VITAX | |
Total Expense Ratio | 1.96 | 0.09 | 2,178% |
Annual Report Gross Expense Ratio | 1.96 | 0.09 | 2,178% |
Fund Existence | 28 years | 21 years | - |
Gain YTD | 2.414 | 0.305 | 792% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 100000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 259M | 99.7B | 0% |
Annual Yield % from dividends | 0.00 | 0.52 | - |
Returns for 1 year | 28.61 | 7.99 | 358% |
Returns for 3 years | 105.10 | 92.91 | 113% |
Returns for 5 years | -5.35 | 135.83 | -4% |
Returns for 10 years | 52.86 | 470.33 | 11% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 29.34 | N/A | N/A |
Fidelity Advisor Biotechnology I | |||
CGACX | 10.86 | -0.10 | -0.91% |
Calvert Global Energy Solutions C | |||
LIDOX | 9.53 | -0.12 | -1.24% |
Lord Abbett International Value F3 | |||
PCSVX | 16.02 | -0.31 | -1.90% |
PACE Small/Medium Co Value Equity P | |||
ASVNX | 8.46 | -0.18 | -2.08% |
American Century Small Cap Value C |